Michael Wiley

Michael Wiley, J.D., CPA, joined the board in 2020. He currently heads up Corporate Affairs at Guardant Health, a public diagnostic laboratory in oncology that he helped found in 2012. Michael was Guardant’s Chief Financial Officer until mid 2016 and its Chief Legal Officer until May 2020. Prior to joining Guardant, Michael worked as CFO at Voyage Medical, a medical device company in the cardiovascular space backed by Kleiner Perkins, Three Arch Partners and Abbott. Before Voyage, Michael was VP of Finance at IntegenX (fka Microchip Biotechnologies) under Dr. Jovanovich. Earlier in his career, Michael was a corporate attorney at Venture Law Group (later Heller Ehrman) and acted as in-house associate counsel for Novell where he focused on intellectual property and employment issues. Before receiving a JD from the J. Reuben Clark Law School at Brigham Young University, Michael worked for KPMG as a tax account. In addition to his current work at Guardant and his board membership with S2 Genomics, Michael sits on the board of LeGrande Corporation (a personalized health company) and is an advisor to Farapulse, Inc. (a medical device company in the cardiovascular space backed by Boston Scientific).